Ascendis Pharma A/SASNDNASDAQ
Loading
Year-over-year total asset growth rate
Latest
12.75%
↑ 25% vs avg
Percentile
P79
Within normal range
Streak
3 qtr
Consecutive growthAccelerating
Average
10.18%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 12.75% |
| Q3 2025 | 6.14% |
| Q2 2025 | 2.49% |
| Q1 2025 | -10.01% |
| Q4 2024 | 7.84% |
| Q3 2024 | 44.24% |
| Q2 2024 | -5.51% |
| Q1 2024 | -2.80% |
| Q4 2023 | -5.45% |
| Q3 2023 | 6.00% |
| Q2 2023 | -14.74% |
| Q1 2023 | -11.33% |
| Q4 2022 | -14.42% |
| Q3 2022 | -4.03% |
| Q2 2022 | -3.66% |
| Q1 2022 | 26.94% |
| Q4 2021 | -9.98% |
| Q3 2021 | 41.48% |
| Q2 2021 | -11.75% |
| Q1 2021 | -1.48% |
| Q4 2020 | -6.34% |
| Q3 2020 | 86.61% |
| Q2 2020 | -9.78% |
| Q1 2020 | -8.18% |
| Q4 2019 | -7.92% |
| Q3 2019 | -4.20% |
| Q2 2019 | 0.68% |
| Q1 2019 | 138.88% |
| Q4 2018 | -4.85% |
| Q3 2018 | -9.12% |
| Q2 2018 | 1.11% |
| Q1 2018 | 72.92% |
| Q4 2017 | -4.98% |
| Q3 2017 | 55.92% |
| Q2 2017 | -17.57% |
| Q1 2017 | -9.11% |
| Q4 2016 | 119.10% |
| Q3 2016 | -15.56% |
| Q2 2016 | -8.83% |
| Q1 2016 | -14.49% |